Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer

BACKGROUND: Pancreatic ductal adenocarcinoma is one of the leading causes of cancer-related death worldwide. Immune checkpoint blockade therapy, including anti-PD-1 and anti-PD-L1, is a new therapeutic strategy for cancer treatment but the monotherapy with PD-L1 inhibitors for pancreatic cancer is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Ping, Zhao, Jingyuan, Meng, Zibo, Wu, Heyu, Wang, Bo, Wu, Heshui, Jin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359760/
https://www.ncbi.nlm.nih.gov/pubmed/30709380
http://dx.doi.org/10.1186/s13046-019-1044-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359760/
https://www.ncbi.nlm.nih.gov/pubmed/30709380
http://dx.doi.org/10.1186/s13046-019-1044-z

Ejemplares similares